EquitAI LogoEquitAI
$126.75
-0.98%
INCY

INCY

Incyte Corporation

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
2/10
Quality
10/10
Growth
7/10
Strength
9/10
Dividend
1/10
Price Trend
Upwards
Momentum
Stretched
Balance Sheet
Healthy
Earnings
Growth
Dividend Yield
0.00%
Market Cap
$25.69B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Incyte Corporation is a specialized biopharmaceutical company that develops and commercializes targeted therapies. Its primary focus is on discovering innovative treatments for rare blood cancers, autoimmune disorders, and inflammatory dermatological conditions. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...